| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |